ORIGINAL RESEARCH article
Front. Physiol.
Sec. Metabolic Physiology
The role of impaired adipogenesis in insulin resistance among non-obese individuals
Provisionally accepted- 1Qatar University, Doha, Qatar
- 2Hamad Medical Corporation, Doha, Qatar
- 3Washington University in St Louis School of Medicine, St. Louis, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Adipogenesis is an essential process for energy storage, hormone regulation, and overall metabolic health. Previous work showed that impaired adipogenesis plays an important role in the development of obesity-associated insulin resistance. This project investigates the role of impaired adipogenesis in the development of insulin resistance among non-obese (lean/overweight) individuals under physiological and pathological microenvironments. Subcutaneous adipose tissue samples were obtained from insulin-sensitive and insulin-resistant non-obese cohorts undergoing maxillofacial or body contouring surgeries. Preadipocytes were isolated and examined for proliferation and adipogenic capacity, insulin signaling, and inflammatory markers. These assessments were conducted under basal conditions and following treatment with either tumor necrosis factor alpha (TNF-α) to induce insulin resistance or metformin to promote insulin sensitivity. Insulin-resistant participants, in comparison to insulin-sensitive counterparts, showed lower adipogenic capacity, higher susceptibility to the anti-adipogenic and pro-inflammatory effect of TNF-α potentially due to hyperphosphorylation of insulin receptor substrate-1. This highlights the role of impaired adipogenesis in the pathogenesis of insulin resistance among non-obese individuals. Further research is needed to understand the impact of impaired adipogenesis and the potential therapeutic interventions targeting adipogenesis to improve insulin sensitivity in non-obese individuals.
Keywords: Adipogenesis, Insulin Resistance, Metformin, Non-obese, tumor necrosis factor alpha
Received: 04 Nov 2025; Accepted: 17 Dec 2025.
Copyright: © 2025 Almuraikhy, Alser, Naja, Anwardeen, Taha, John, Halim, Badran, Ahmed, Jarrar, Aljassem, Al-Mohannadi, Doi, Abdel-Aziz, Elaf and Elrayess. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mohamed A. Elrayess
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
